Cargando…
Treatment targets in systemic lupus erythematosus: biology and clinical perspective
Systemic lupus erythematosus (SLE) is a complex disease characterized by numerous autoantibodies and clinical involvement in multiple organ systems. The immunological events triggering the onset and progression of clinical manifestations are also complex and multi-step, including breach of tolerance...
Autores principales: | Marian, Valentin, Anolik, Jennifer H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535717/ https://www.ncbi.nlm.nih.gov/pubmed/23281796 http://dx.doi.org/10.1186/ar3917 |
Ejemplares similares
-
Biological therapies and their clinical impact in the treatment of
systemic lupus erythematosus
por: Magro, Rosalie
Publicado: (2019) -
Systemic lupus erythematosus is characterized by faulty B-cell tolerance in the germinal centers
por: Anolik, J, et al.
Publicado: (2004) -
Lupus erythematosus tumidus: clinical perspectives
por: Patsinakidis, Nikolaos, et al.
Publicado: (2019) -
Development of targeted biologics for systemic lupus erythematosus
por: Lipsky, Peter E
Publicado: (2012) -
Belimumab: First targeted biological treatment for systemic lupus erythematosus
por: Dubey, Ashok K., et al.
Publicado: (2011)